Showing 31-40 of 137 results for "".
Hair’s the Thing
https://practicaldermatology.com/topics/hair-nails/hairs-the-thing/23909/Dermatologists can take a more proactive role in caring for patients with alopecia.Currents: Think Big
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents-think-big/20893/Big picture approaches can unlock new solutions to dermatologic diseases.Backdoor Roth IRA Strategy in 2021
https://practicaldermatology.com/topics/practice-management/backdoor-roth-ira-strategy-in-2021/23480/As tax increases may come for high-income earners, we offer an effective step toward tax diversification.New In My Practice: Rx
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rx/23242/Editorial Board Forum, Part II: What the Future Holds for Dermatology
https://practicaldermatology.com/topics/practice-management/editorial-board-forum-part-ii-what-the-future-holds-for-dermatology/21447/Lichen Amyloidosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/lichen-amyloidosis/20681/Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.Aerolase’s Neo Elite 650-Microsecond 1064nm Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aerolases-neo-elite-650-microsecond-1064nm-laser/23243/A Safe, Effective Go-to Option to Treat Skin of ColorCritical Factors to Advancing Melanoma Diagnosis and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/critical-factors-to-advancing-melanoma-diagnosis-and-treatment/22970/Dermatologists need to stay abreast of technologies for evaluation of lesions and ensure that medical oncologists within their referral network recognize the importance of clinical trials.AbbVie's Skyrizi Approved, Brooke Shields Endorses SculpSure
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-abbvies-skyrizi-approved-brooke-shi/19607/Skyrizi, an interleukin-23 inhibitor from AbbVie, is FDA approved for the treatment of moderate to severe plaque psoriasis in adults. Brooke Shields is the face of the new “Be strong. Be sexy. Be confident” campaign for SculpSure, from Hologic’s Cynosure. The Noah Worcester Dermatological Society an